questionText: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential impact of NICE’s rejection of trastuzumab deruxtecan for use in secondary breast cancer treatment on patient outcomes.
heading: Trastuzumab Deruxtecan